Back On Track: Biopharmaceutical Sector Sees M&A Revival

Dr. Dmitry Reykhart, Chairman of the Ruthenium Global Pharma Fund Board of Directors.
getty
The biopharmaceutical sector has experienced a revival in mergers and acquisitions in the second half of …

https://www.forbes.com/sites/forbesfinancecouncil/2024/01/03/back-on-track-biopharmaceutical-sector-sees-ma-revival/